Treatment delay and facility case volume are associated with survival in early-stage glottic cancer-Reference-Cited by-同舟云学术

Treatment delay and facility case volume are associated with survival in early-stage glottic cancer

Published:2016-09-22 Issue:3 Volume:127 Page:616-622
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Cheraghlou Shayan¹,Kuo Phoebe¹,Judson Benjamin L.¹

Affiliation:

1. Department of Surgery; Yale School of Medicine; New Haven Connecticut U.S.A.

Funder

Yale University School of Medicine Lowe Endowment

Publisher

Wiley

Subject

Otorhinolaryngology

Reference44 articles.

1. American Cancer Society What are the key statistics about laryngeal and hypopharyngeal cancers? http://www.cancer.org/cancer/laryngealandhypopharyngealcancer/detailedguide/laryngeal-and-hypopharyngeal-cancer-key-statistics 2016

2. Epidemiology, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital;Dechaphunkul;J Med Assoc Thai,2011

3. Laryngeal cancer: diagnosis and preoperative work-up;Chu;Otolaryngol Clin North Am,2008

4. Glottic cancer in patients without complaints of hoarseness;Tachibana;Head Neck,2016

5. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis;Raitiola;Acta Otolaryngol,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extranodal extension in laryngeal squamous cell carcinoma;Laryngoscope Investigative Otolaryngology;2024-03-25

2. Sobrevida del cáncer glótico en estadio inicial en 4 centros hospitalarios de Uruguay;Anales de la Facultad de Medicina;2024-03-20

3. Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors;Head & Neck;2024-03-14

4. High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization;Archives of Dermatological Research;2024-02-13

5. Predictors of prolonged treatment time intervals in oral cavity cancer;Oral Oncology;2023-12